awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33597441-B5F235E3-99E5-49BD-85A2-172340F357C3
Q33597441-B5F235E3-99E5-49BD-85A2-172340F357C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33597441-B5F235E3-99E5-49BD-85A2-172340F357C3
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.
P2860
Q33597441-B5F235E3-99E5-49BD-85A2-172340F357C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33597441-B5F235E3-99E5-49BD-85A2-172340F357C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fde6acb3975931dcc78d6e96a2f4b63ad067aa03
P2860
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada